| Patents for C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704) |
|---|
| 04/23/2002 | US6376670 Bactericide for grampositive bacteria |
| 04/23/2002 | US6376510 Administering a alkoxy- and acyloxy-substituted aralkyl and aralkenyl bis quaternary ammonium derivatives of cyclic alkanol diesters to a human as muscle relaxants |
| 04/23/2002 | US6376507 NK-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | US20020045750 Asymetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. |
| 04/11/2002 | WO2002028847A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | US20020042429 Quinuclidine-substituted heteroaryl moieties for treatment of disease |
| 04/11/2002 | US20020042428 Central nervous system disorders |
| 04/11/2002 | US20020042426 Novel basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | CA2424279A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/10/2002 | EP1037891B1 Method for preparing mequitazine and novel synthesis intermediate |
| 04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1082371C NK-1 receptor antagonist and 5HT3 receptor antagonists for treating emesis |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/09/2002 | US6369053 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 04/04/2002 | US20020040035 Quinuclidine-substituted aryl compounds for treatment of disease |
| 04/03/2002 | EP1193261A1 New thiadiazoles and their use as phosphodiesterase-7 inhibitors |
| 04/02/2002 | US6365125 Using organotin compound |
| 03/28/2002 | WO2002024692A1 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 03/28/2002 | WO2001076571A3 Use of sabcomeline in the treatment of anxiety |
| 03/27/2002 | EP1189913A1 Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 03/27/2002 | EP1189903A1 Novel benzo f]naphthyridine, preparation and compositions containing them |
| 03/27/2002 | EP0786998B1 Use of r-(z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2] oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease |
| 03/27/2002 | CN1342157A Substituted pyrazoles ASP38 kinase inhibitors |
| 03/27/2002 | CN1342150A Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 03/27/2002 | CN1081633C 1,2,4-benzothiadiazine derivatives, their preparation and use |
| 03/21/2002 | WO2002022598A1 Quinolinone derivatives as tyrosine kinase inhibitors |
| 03/21/2002 | US20020035147 Nervous system, psychological disorders |
| 03/21/2002 | DE10045112A1 Verwendung von Indolderivaten zur Behandlung von Erkrankungen des zentralen Nervensystems The use of indole derivatives for the treatment of diseases of the central nervous system |
| 03/20/2002 | EP1187834A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2,2,2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as nk-1 receptor antagonists |
| 03/20/2002 | EP1187813A1 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020521A1 Use of indole derivatives for treating illnesses of the central nervous system |
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/07/2002 | WO2002018334A2 Sodium channel modulators |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6352995 Spiro-quinuclidine derivatives, their preparation and use |
| 02/28/2002 | WO2002017358A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists) |
| 02/28/2002 | WO2002016358A2 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 02/28/2002 | WO2002016357A2 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 02/28/2002 | WO2002016356A2 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 02/28/2002 | WO2002016355A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands |
| 02/28/2002 | WO2002015906A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | WO2002015662A2 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists |
| 02/28/2002 | CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/27/2002 | EP1181290A1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 02/27/2002 | EP1181289A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
| 02/21/2002 | WO2002014311A2 Urea compounds and methods of uses |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/12/2002 | CA2227194C Resolution of 1-azabicyclo[2.2.2]octan-3-amine, 2-(diphenylmethyl)-n-[[2-methoxy-5-(1-methylethyl)phenyl]methyl] |
| 02/07/2002 | WO2002010177A1 Ammonium salts of inositol hexaphosphate and uses thereof |
| 02/07/2002 | WO2002010146A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | WO2002010096A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 02/07/2002 | CA2417638A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 02/07/2002 | CA2416303A1 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
| 02/05/2002 | CA2078578C Medical use for tachykinin antagonists |
| 01/30/2002 | EP1175417A1 Substituted benzolactam compounds |
| 01/24/2002 | WO2001058869A3 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 01/24/2002 | WO2001029000A3 Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
| 01/24/2002 | WO2001023385A3 Novel tropane analogs |
| 01/23/2002 | EP0711292B1 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
| 01/23/2002 | CN1332726A Pyrrolidine compounds and medicinal utilizaion thereof |
| 01/16/2002 | EP1172106A2 Use of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles as substance P receptor antagonists |
| 01/16/2002 | EP1171432A1 Adamantane derivatives |
| 01/16/2002 | EP0790246B1 Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof |
| 01/15/2002 | CA2039826C Spiro bridged and unbridged heterocyclic compounds |
| 01/10/2002 | WO2002002556A2 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 01/10/2002 | CA2415088A1 Aza-bridged-bicyclic amino acid derivatives as .alpha.4 integrin antagonists |
| 01/09/2002 | EP0585328B1 Substituted 3-aminoquinuclidines |
| 01/03/2002 | WO2002000656A2 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives |
| 01/03/2002 | WO2002000652A1 Carbamates derived from arylalkylamines |
| 01/02/2002 | EP1165076A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 12/20/2001 | WO2001096279A1 Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/13/2001 | WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 12/12/2001 | EP0981340B1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 12/11/2001 | US6329394 Medical use for tachykinin antagonists |
| 12/11/2001 | CA2226292C Substituted benzolactam compounds as substance p antagonists |
| 12/06/2001 | WO2001092280A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 12/06/2001 | WO2001046188B1 Optically active isomers of quinine and quinidine and their respective biological action |
| 12/06/2001 | US20010049379 Nitric oxide synthase inhibitors; treatment and prevention of central nervous system and other disorders. |
| 12/06/2001 | CA2410643A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 12/04/2001 | US6326383 Emesis therapy |
| 12/04/2001 | US6326327 Process for preparing MeO-Peg-protected dihydroquinine or dihydroquinidine derivatives, new dihydroquinine or dihydroquinidine derivatives and their use |
| 11/29/2001 | WO2001090107A1 Ammonium compounds bearing an electrophilic fluorine, reagent containing same, method using same and synthesis method for obtaining them |
| 11/27/2001 | US6323216 Selective antagonists of the 5-ht.sub.3 serotonin-like receptor and can therefore be used, as anti-emetics as well as in various pathological conditions of the central nervous system, and as antitussives. |
| 11/22/2001 | WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents |
| 11/22/2001 | CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents |
| 11/21/2001 | EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them |
| 11/21/2001 | EP0659179B1 Benzo-fused lactams promote release of growth hormone |
| 11/15/2001 | WO2001085727A1 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 11/14/2001 | EP1098883A4 Process for preparing heterocyclic compounds |
| 11/14/2001 | CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them |